Vasodilator-responsive idiopathic pulmonary arterial hypertension: evidence for a new disease?
作者信息
Brittain Evan L, Hemnes Anna R
出版信息
Ann Intern Med. 2015 Jan 20;162(2):148-9. doi: 10.7326/M14-2700.
Abstract
摘要
相似文献
1
Vasodilator-responsive idiopathic pulmonary arterial hypertension: evidence for a new disease?血管扩张剂反应性特发性肺动脉高压：一种新疾病的证据？
Ann Intern Med. 2015 Jan 20;162(2):148-9. doi: 10.7326/M14-2700.
2
Acute vasodilator responsiveness and microvascular recruitment in idiopathic pulmonary arterial hypertension.特发性肺动脉高压中的急性血管扩张剂反应性和微血管募集
Ann Intern Med. 2015 Jan 20;162(2):154-6. doi: 10.7326/M14-1402.
3
Management of a child with pulmonary arterial hypertension presenting with systemic hypertension.
Cardiol Young. 2016 Feb;26(2):378-81. doi: 10.1017/S1047951115001092. Epub 2015 Jun 17.
4
Pulmonary Vascular Capacitance is Associated with Vasoreactivity and Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension.肺血管容量与特发性肺动脉高压患者的血管反应性及对钙通道阻滞剂的长期反应相关。
Lung. 2016 Aug;194(4):613-8. doi: 10.1007/s00408-016-9905-0. Epub 2016 Jun 7.
5
Treatment of idiopathic/hereditary pulmonary arterial hypertension.特发性/遗传性肺动脉高压的治疗
J Cardiol. 2014 Oct;64(4):243-9. doi: 10.1016/j.jjcc.2014.06.009. Epub 2014 Jul 28.
6
Idiopathic pulmonary arterial hypertension in Asians: a long-term study on clinical outcomes.亚洲人群特发性肺动脉高压：临床结局的长期研究
Chest. 2015 Apr;147(4):e160-e163. doi: 10.1378/chest.14-2919.
7
Therapy for pulmonary arterial hypertension: approved dosages should be prescribed in clinical practice.
Chest. 2015 Oct;148(4):e126. doi: 10.1378/chest.15-1215.
8
9
Perioperative management with upfront combination therapy in a patient exhibiting idiopathic pulmonary hypertension with central pulmonary thrombosis.
Intern Med. 2014;53(7):777-81. doi: 10.2169/internalmedicine.53.1355. Epub 2012 Mar 1.
10
Effect of calcium channel blockers evaluated by cardiopulmonary exercise testing in idiopathic pulmonary arterial hypertension responding to acute pulmonary vasoreactivity testing.通过心肺运动试验评估钙通道阻滞剂对特发性肺动脉高压患者急性肺血管反应性试验阳性者的疗效。
Pulm Pharmacol Ther. 2017 Apr;43:26-31. doi: 10.1016/j.pupt.2017.01.012. Epub 2017 Feb 1.
引用本文的文献
1
PeakPCO combined with FEV1/FVC predicts vasodilator-responsive patients with idiopathic pulmonary arterial hypertension.呼气末二氧化碳分压峰值（PeakPCO）联合第一秒用力呼气容积与用力肺活量比值（FEV1/FVC）可预测对血管扩张剂有反应的特发性肺动脉高压患者。
Pulm Circ. 2021 Dec 2;11(4):20458940211059713. doi: 10.1177/20458940211059713. eCollection 2021 Oct-Dec.
2
Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?巨噬细胞免疫调节：骨髓间充质干细胞衍生外泌体在肺动脉高压中的“守门员”？
Int J Mol Sci. 2018 Aug 27;19(9):2534. doi: 10.3390/ijms19092534.
3
Vasodilator responsiveness in idiopathic pulmonary arterial hypertension: identifying a distinct phenotype with distinct physiology and distinct prognosis.特发性肺动脉高压中的血管扩张剂反应性：识别具有不同生理特征和不同预后的独特表型。
Pulm Circ. 2017 Jul-Sep;7(3):588-597. doi: 10.1177/2045893217714231. Epub 2017 Jun 20.
本文引用的文献
1
Acute vasodilator responsiveness and microvascular recruitment in idiopathic pulmonary arterial hypertension.特发性肺动脉高压中的急性血管扩张剂反应性和微血管募集
Ann Intern Med. 2015 Jan 20;162(2):154-6. doi: 10.7326/M14-1402.
2
Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension.血管扩张剂反应性肺动脉高压的外周血特征
Circulation. 2015 Jan 27;131(4):401-9; discussion 409. doi: 10.1161/CIRCULATIONAHA.114.013317. Epub 2014 Oct 31.
3
Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertension.前列腺素类药物而非口服疗法可改善肺动脉高压患者的右心室功能。
JACC Heart Fail. 2013 Aug;1(4):300-307. doi: 10.1016/j.jchf.2013.05.004.
4
An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.从 REVEAL 注册研究评估肺动脉高压诊断后患者的长期生存。
Chest. 2012 Aug;142(2):448-456. doi: 10.1378/chest.11-1460.
5
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.特发性肺动脉高压患者对钙通道阻滞剂的长期反应
Circulation. 2005 Jun 14;111(23):3105-11. doi: 10.1161/CIRCULATIONAHA.104.488486. Epub 2005 Jun 6.
6
Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury.急性肺损伤中肺毛细血管内皮结合的血管紧张素转换酶活性
Circulation. 2000 Oct 17;102(16):2011-8. doi: 10.1161/01.cir.102.16.2011.
7
Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in humans.
Circulation. 1999 Mar 30;99(12):1593-9. doi: 10.1161/01.cir.99.12.1593.
8
High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.
Circulation. 1987 Jul;76(1):135-41. doi: 10.1161/01.cir.76.1.135.
9
Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents.原发性肺动脉高压。血管结构、形态测定以及对血管扩张剂的反应性。
Circulation. 1989 Nov;80(5):1207-21. doi: 10.1161/01.cir.80.5.1207.
Zotero 插件